Your session is about to expire
← Back to Search
Neural Stimulation
Neural Stimulation for Schizophrenia
N/A
Waitlist Available
Research Sponsored by The University of Texas at Dallas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in daily expectations of social interactions will be assessed from the pre-stimulation ema period (7 days before the stimulation visit) to the post-stimulation ema period (7 days after the stimulation visit)
Awards & highlights
Study Summary
This trial will assess whether stimulating the brain can improve symptoms & functioning in people with schizophrenia-like disorders.
Who is the study for?
This trial is for adults aged 18-60 with schizophrenia or schizoaffective disorder experiencing recent paranoia. It's not suitable for pregnant individuals, those with certain developmental disorders, neurological conditions like epilepsy, active substance use disorders, severe sensory impairments, a history of electroconvulsive therapy, non-English speakers, or anyone with implanted medical devices.Check my eligibility
What is being tested?
The study investigates if brain stimulation through transcranial Direct Current Stimulation (tDCS) can alleviate psychotic symptoms and improve social functioning in people with schizophrenia spectrum disorders.See study design
What are the potential side effects?
Potential side effects of tDCS may include discomfort at the electrode site on the scalp, itching or tingling during stimulation, fatigue after treatment sessions, headache or nausea.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change in daily paranoia feelings will be assessed from the pre-stimulation ema period (7 days before the stimulation visit) to the post-stimulation ema period (7 days after the stimulation visit)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in daily paranoia feelings will be assessed from the pre-stimulation ema period (7 days before the stimulation visit) to the post-stimulation ema period (7 days after the stimulation visit)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Paranoid Ideation for Active vs. Sham Stimulation
Social functioning for Active vs. Sham Stimulation
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active anodal tDCS first, then Sham tDCSExperimental Treatment1 Intervention
Active anodal tDCS (40 minutes; divided into two 20-minutes sessions) followed by behavioral testing; Washout (about 1 week); sham stimulation (40 minutes; divided into two 20-minutes sessions) followed by behavioral testing.
Group II: Sham tDCS first, then Active anodal tDCSPlacebo Group1 Intervention
Sham tDCS (40 minutes; divided into two 20-minutes sessions) followed by behavioral testing; Washout (about 1 week); Active anodal tDCS (40 minutes; divided into two 20-minutes sessions) followed by behavioral testing Intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
tDCS
2017
Completed Phase 2
~640
Find a Location
Who is running the clinical trial?
The University of Texas at DallasLead Sponsor
58 Previous Clinical Trials
106,225 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have undergone electroconvulsive therapy.I do not have a history of epilepsy or seizures.I have vision or hearing problems that cannot be corrected.I have experienced paranoia in the last month.I am between 18 and 64 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Active anodal tDCS first, then Sham tDCS
- Group 2: Sham tDCS first, then Active anodal tDCS
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is participation in this research endeavor open to volunteers at the moment?
"This clinical trial, posted on November 21st 2022 and last updated February 24th 2023 is seeking participants. According to the information hosted by clinicaltrials.gov this trial is currently recruiting patients."
Answered by AI
Is the age limit of this clinical trial restricted to those over 50 years old?
"This trial is tailored to individuals between the age of 18 and 60. There are 104 studies available for patients younger than 18, while 258 trials exist for subjects above 65 years old."
Answered by AI
Does this research offer an opportunity for my participation?
"To qualify for this trial, individuals must have schizophrenia and be within the age range of 18 to 60 years old. Currently, up to 65 patients are being accepted in total."
Answered by AI
How many participants are eligible for this research project?
"Assertion affirmed. According to clinicaltrials.gov, the recruitment period for this trial began on November 21st 2022 and is still ongoing as of February 24th 2023. There are 65 participants required from 1 medical center."
Answered by AI
Who else is applying?
What site did they apply to?
The Unversity of Texas at Dallas
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
How responsive is this trial?
Typically responds via
Phone Call
Email
Most responsive sites:
- The Unversity of Texas at Dallas: < 48 hours
Average response time
- < 2 Days
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger